Highbridge Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Highbridge Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,879	Closed	-$207K	–	2073
2016 Q1	$207K	Sell	3,879 -46,530	-92%	-$3.43M	﹤0.01%	1331
2015 Q4	$5.7M	Sell	50,409 -29,752	-37%	-$3.28M	0.09%	256
2015 Q3	$9.44M	Buy	80,161 +19,388	+32%	+$2.53M	0.15%	192
2015 Q2	$4.71M	Buy	60,773 +37,656	+163%	+$2.47M	0.06%	323
2015 Q1	$1.34M	Buy	+23,117	New	+$981K	0.02%	652

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Highbridge Capital Management's ANAC Position: Q2 2016 in Review

Highbridge Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 3,879 shares — an estimated $207K sold.

Highbridge Capital Management first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $9.44M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Highbridge Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Highbridge Capital Management sold 3,879 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $207K.
Highbridge Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
Highbridge Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $9.44M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Highbridge Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.